TICKERNERD
Menu
CLXCLXConsumer Defensive · Household & Personal Products

CLX Stock Forecast: The Clorox Co. Price Predictions for 2026-2027

Last close, 17 Aug 2026
$106
+0.20% on the day

The 19 Wall Street analysts covering The Clorox Co. hold a median 12-month price target of $100 — -5.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 28 of 100 as at 17 Aug 2026 — in the lower half.

Market cap
$12.8B
Ticker Nerd rank
28 / 100
Median analyst target
$100
Analysts covering
19
Total return, dividends reinvested
1W
−0.5%
1M
+11.2%
YTD
+8.8%
1Y
−9.3%
From 52W high
−14.7%
From 52W low
+24.4%
$85
$124
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CLX stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores The Clorox Co. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 17 Aug 2026
28 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
84
Volatility
84
Value
59
Revisions
50
Issuance
36
Momentum
32
Growth
21
Accruals
21
Size
14

Quality (84): The business earns solid, repeatable profits on what it owns.

Accruals (21): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (14): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CLX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CLX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$80$100$120$140$160Oct 25Jan 26Apr 26Jul 26CLXHigh $155Median $100Low $77

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says19 analysts
1 Buy14 Hold4 Sell
Low $77Median $100High $155

The green dot is the last close — the median target sits −5.6% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 7 moved their price target up and 4 moved it down.

DateFirmActionRatingTarget
4 Aug 2026CitigroupMaintainsNeutral$97 → $100
4 Aug 2026Evercore ISI GroupMaintainsUnderperform$98 → $99
4 Aug 2026JP MorganMaintainsUnderweight$92 → $95
4 Aug 2026UBSMaintainsNeutral$100 → $105
4 Aug 2026Wells FargoMaintainsEqual-Weight$95 → $102
28 July 2026JefferiesDowngradeHold$125 → $98
23 July 2026Evercore ISI GroupMaintainsUnderperform$110 → $98
23 July 2026Evercore ISI GroupMaintainsUnderperform—
21 July 2026BarclaysMaintainsUnderweight$85 → $86
21 July 2026BarclaysMaintainsUnderweight—
20 July 2026BNP ParibasMaintainsNeutral$97 → $95
20 July 2026BNP ParibasMaintainsNeutral—
16 July 2026JP MorganMaintainsUnderweight—
16 July 2026JP MorganMaintainsUnderweight$95 → $92
16 July 2026UBSMaintainsNeutral—
16 July 2026UBSMaintainsNeutral$96 → $100
18 May 2026Wells FargoMaintainsEqual-Weight—
4 May 2026BarclaysMaintainsUnderweight—
1 May 2026CitigroupMaintainsNeutral—
1 May 2026Evercore ISI GroupMaintainsUnderperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CLX appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

CLX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−8.0%
Analysts raising
0
Analysts cutting
11
Fundamentals

The Clorox Co. (CLX) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
22.0×

Cheaper than 36% of US stocks

Price / sales
1.9×

Cheaper than 55% of US stocks

Price / book
142.1×

Cheaper than 1% of US stocks

EV / EBITDA
16.1×

Cheaper than 22% of US stocks

Growth & margins
Revenue growth (YoY)
−2.0%

Higher than 24% of US stocks

Earnings growth (YoY)
−50.9%

Higher than 10% of US stocks

Gross margin
41.3%

Higher than 52% of US stocks

Operating margin
12.9%

Higher than 69% of US stocks

Net margin
8.7%

Higher than 67% of US stocks

Returns & dividend
Return on equity
163.8%

Higher than 98% of US stocks

Return on assets
8.3%

Higher than 89% of US stocks

Dividend yield
4.7%

Higher than 82% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

CLX vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHousehold & Personal Products
CompanyMarket capTKN rank
CLXThe Clorox Co.$12.8B
28
CHDChurch & Dwight Co., Inc.$23.9B
66
ELThe Estée Lauder Companies, Inc.$29.5B
71
ELFe.l.f. Beauty, Inc.$5.6B
37
KMBKimberly-Clark Corp.$35.8B
63
KVUEKenvue, Inc.$36.1B
64
IPARInterparfums, Inc.$3.6B
81

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own The Clorox Co. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CLX news & analysis

NWL vs. CLX: Which Stock Is the Better Value Option?

Zacks Investment Research · 6 Aug 2026neutral

A Zacks Investment Research article compares Newell Brands (NWL) and Clorox (CLX) in the Consumer Products - Staples sector, exploring which of the two is the better choice for investors looking for undervalued stocks. The excerpt poses the question but does not provide a conclusion.

Why it matters — CLX watchers would care because the article assesses whether Clorox stacks up as an undervalued option relative to a sector peer.

Clorox Q4 Earnings & Sales Top Estimates as GOJO Supports Sales

Zacks Investment Research · 4 Aug 2026neutral

The Clorox Co. beat Wall Street estimates for fourth-quarter sales and earnings, with its GOJO business supporting sales. However, lower volume and rising costs are pressuring margins and profits.

Why it matters — CLX watchers would care because the estimate beat is offset by weak volumes and cost pressures that are squeezing margins and profits, signaling mixed underlying momentum.

CLX Q4 Earnings Call Flags Inflation as Share Recovery Builds

Zacks Investment Research · 4 Aug 2026neutral

On Clorox's Q4 earnings call, the company said it expects fiscal 2027 sales to rise, helped by GOJO and ERP comparisons, while flagging that inflation, muted categories and value-seeking consumers cloud the recovery even as share recovery builds.

Why it matters — A CLX watcher would care because the company sees a path to fiscal 2027 sales growth via GOJO and ERP comparisons while acknowledging consumer and cost pressures that could shape the pace of its share recovery.

Clorox: Follow Consumers Trends By Seeking Value Elsewhere (Rating Downgrade)

Seeking Alpha · 4 Aug 2026negative

Seeking Alpha downgraded Clorox's rating, citing volatile fiscal Q4 results affected by the GOJO acquisition and ERP disruption. The article notes weak underlying organic sales, pressure from private label brands, and Clorox's difficulty passing higher input costs into prices.

Why it matters — CLX watchers would care because the report points to softer underlying demand, competitive pressure from private labels, and margin challenges tied to input-cost inflation.

FAQ

Frequently asked questions about CLX stock

What is the CLX stock price forecast for 2026-2027?

The 19 Wall Street analysts covering The Clorox Co. have a median 12-month price target of $100, with estimates ranging from $77 to $155. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CLX stock a buy right now?

Of the 19 analysts covering The Clorox Co., 1 rate it a Buy, 14 a Hold and 4 a Sell. Ticker Nerd's systematic factor model ranks The Clorox Co. 28 out of 100 across roughly 4,600 US stocks as at 17 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CLX?

As at 17 Aug 2026, The Clorox Co. ranks 28 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (84 of 100).

Will CLX stock go up?

No one can know that. What the data says: the median 12-month target from 19 analysts implies -5.6% from the last close, and Ticker Nerd's factor model ranks The Clorox Co. 28 out of 100 as at 17 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CLX stock forecast for 2030?

No analyst covering The Clorox Co. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CLX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $77 to $155 over the next 12 months.

How has CLX stock performed over the past year?

The Clorox Co. returned -9.3% over the 12 months to 17 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does The Clorox Co. do?

The Clorox Company is a consumer products manufacturer focused on household, health, and lifestyle brands used in everyday cleaning and personal care. Based in Oakland, California and founded in 1913, the company operates through four main segments: Health and Wellness, Household, Lifestyle, and International.

What is the latest news on CLX?

The most recent item we track (Zacks Investment Research, 6 Aug 2026): "NWL vs. CLX: Which Stock Is the Better Value Option?". A Zacks Investment Research article compares Newell Brands (NWL) and Clorox (CLX) in the Consumer Products - Staples sector, exploring which of the two is the better choice for investors looking for undervalued stocks. The excerpt poses the question but does not provide a conclusion.

Company

About The Clorox Co.

The Clorox Company is a consumer products manufacturer focused on household, health, and lifestyle brands used in everyday cleaning and personal care. Based in Oakland, California and founded in 1913, the company operates through four main segments: Health and Wellness, Household, Lifestyle, and International. Its Health and Wellness portfolio includes cleaning and disinfecting products, bleach, laundry additives, and professional hygiene solutions used in homes and commercial settings. The Household segment covers trash bags, food storage, cat litter, and related home care products. Lifestyle offerings include food dressings, sauces, and water filtration, while the International segment distributes many of these brands globally. The Clorox Company owns a broad range of well-known names across cleaning, food, personal care, and filtration, serving both consumer and professional customers worldwide and playing a significant role in the consumer staples and household and personal products industry.

CEO Ms. Linda J. Rendle · 9,200 employees · United States · https://www.thecloroxcompany.com